Riemer R K, Wu Y Y, Bottari S P, Jacobs M M, Goldfien A, Roberts J M
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco 94143.
Mol Pharmacol. 1988 Apr;33(4):389-95.
The uterine contractile response to adrenergic agonists or sympathetic stimulation is influenced dramatically by the hormonal milieu. Rabbit uterine contraction is mediated by alpha 1-adrenoceptors, whereas relaxation in response to the same stimulus is mediated by beta 2-adrenoceptors. Whether uterine contractility is increased or decreased by adrenergic stimulation is determined by the gonadal steroids estrogen and progesterone: uterine contraction prevails in the estrogen-dominant or the ovariectomized animal, but in the progesterone-dominant rabbit, uterine relaxation is observed. In previous studies, we have demonstrated that changes in the concentration or agonist affinity of these adrenoceptors cannot account for the changes in contractile response. In the present studies, we tested whether sex steroids might alter beta-adrenergic response by acting on events distal to receptor occupancy, and whether this could explain the conversion of contractile response. We found that myometrial cAMP generation is potently stimulated by beta-agonists in progesterone-treated and also in ovariectomized animals, but this stimulation is absent after estrogen treatment. Similar, but smaller, changes were observed for cAMP generation in response to prostaglandin E2 and forskolin. Stimulation of adenylate cyclase in uterine particulates by agents which act on the guanyl nucleotide-sensitive stimulatory transducer, Gs, is unchanged after estrogen treatment. However, specific labeling of Gs catalyzed by cholera toxin is reduced in membrane particulates from estrogen-treated animals. Recombination of extracts of uterine membranes from the differently treated animals also suggested qualitative differences in Gs. We conclude that at least one component of the adenylate cyclase cascade beyond the beta-adrenoceptor, i.e., Gs, is a target for ovarian steroids; estrogen reduces Gs labeling and beta-adrenoceptor-mediated cAMP production. However, uterine Gs labeling and cAMP production are similar in ovariectomized and in progesterone-treated rabbits. Since these uteri exhibit different contractile responses, the observed changes are not sufficient to explain sex steroid-mediated conversion of myometrial contractile response.
子宫对肾上腺素能激动剂或交感神经刺激的收缩反应受激素环境的显著影响。兔子宫收缩由α1-肾上腺素能受体介导,而对相同刺激的松弛反应则由β2-肾上腺素能受体介导。肾上腺素能刺激使子宫收缩力增强还是减弱取决于性腺甾体激素雌激素和孕酮:在雌激素占优势或去卵巢的动物中子宫收缩占主导,但在孕酮占优势的兔中则观察到子宫松弛。在先前的研究中,我们已经证明这些肾上腺素能受体的浓度或激动剂亲和力的变化不能解释收缩反应的变化。在本研究中,我们测试了性甾体激素是否可能通过作用于受体占据后的远端事件来改变β-肾上腺素能反应,以及这是否可以解释收缩反应的转变。我们发现,在孕酮处理的动物以及去卵巢的动物中,β-激动剂能有效刺激子宫肌层cAMP的生成,但雌激素处理后这种刺激消失。对前列腺素E2和福斯高林的反应中,cAMP生成也观察到类似但较小的变化。雌激素处理后,作用于鸟苷酸敏感刺激转导子Gs的试剂对子宫微粒体中腺苷酸环化酶的刺激作用未改变。然而,雌激素处理动物的膜微粒体中霍乱毒素催化的Gs特异性标记减少。不同处理动物的子宫膜提取物的重组也表明Gs存在质的差异。我们得出结论,腺苷酸环化酶级联反应中至少一个位于β-肾上腺素能受体之外的成分,即Gs,是卵巢甾体激素的作用靶点;雌激素降低Gs标记和β-肾上腺素能受体介导的cAMP生成。然而,去卵巢的兔和孕酮处理的兔子宫的Gs标记和cAMP生成相似。由于这些子宫表现出不同的收缩反应,观察到的变化不足以解释性甾体激素介导的子宫肌层收缩反应的转变。